Filters: 2022




20160128 EGA Regulatory and Scientific Affairs Conferenc

Call on EU leaders to safeguard access to medicines and build resilience in response to Russia-Ukraine war

23 March 2022

The supply of medicines is critical yet unstable as war […]

Read more

“Better patient access to medicines and restoring Europe’s (manufacturing) security of supply more critical than ever” says new President, as Elisabeth Stampa begins mandate

7 March 2022

The Covid-19 pandemic has highlighted the critical link between patient […]

Read more

Statement on the war in Ukraine

4 March 2022

Collaboration Since the beginning of the war in Ukraine, Medicines […]

Read more

Essential medicines must be included in EU industrial policy plans

3 March 2022

Political ambitions to strengthen EU supply chain resilience following the […]

Read more

Electronic product information: new report shows it is time to move from principles to action

24 February 2022


Supply crunch for essential cancer medicines shows the urgent need to revise unsustainable pricing and tendering policies

16 February 2022

Reports of supply shortages of breast cancer medicine (Tamoxifen) in […]

Read more

The European Commission needs to prioritise equitable access to biosimilar medicines in Europe

25 January 2022

Over 15 years ago, the world’s first biosimilar was launched. […]

Read more

Regulatory reforms critical to improve patient access to medicines

24 January 2022

The ongoing review of the EU pharmaceutical legislation framework is […]

Read more

Subscribe to our newsletter